High-fat diet induces hepatic insulin resistance and impairment of synaptic plasticity

PLoS One. 2015 May 29;10(5):e0128274. doi: 10.1371/journal.pone.0128274. eCollection 2015.

Abstract

High-fat diet (HFD)-induced obesity is associated with insulin resistance, which may affect brain synaptic plasticity through impairment of insulin-sensitive processes underlying neuronal survival, learning, and memory. The experimental model consisted of 3 month-old C57BL/6J mice fed either a normal chow diet (control group) or a HFD (60% of calorie from fat; HFD group) for 12 weeks. This model was characterized as a function of time in terms of body weight, fasting blood glucose and insulin levels, HOMA-IR values, and plasma triglycerides. IRS-1/Akt pathway was assessed in primary hepatocytes and brain homogenates. The effect of HFD in brain was assessed by electrophysiology, input/output responses and long-term potentiation. HFD-fed mice exhibited a significant increase in body weight, higher fasting glucose- and insulin levels in plasma, lower glucose tolerance, and higher HOMA-IR values. In liver, HFD elicited (a) a significant decrease of insulin receptor substrate (IRS-1) phosphorylation on Tyr608 and increase of Ser307 phosphorylation, indicative of IRS-1 inactivation; (b) these changes were accompanied by inflammatory responses in terms of increases in the expression of NFκB and iNOS and activation of the MAP kinases p38 and JNK; (c) primary hepatocytes from mice fed a HFD showed decreased cellular oxygen consumption rates (indicative of mitochondrial functional impairment); this can be ascribed partly to a decreased expression of PGC1α and mitochondrial biogenesis. In brain, HFD feeding elicited (a) an inactivation of the IRS-1 and, consequentially, (b) a decreased expression and plasma membrane localization of the insulin-sensitive neuronal glucose transporters GLUT3/GLUT4; (c) a suppression of the ERK/CREB pathway, and (d) a substantial decrease in long-term potentiation in the CA1 region of hippocampus (indicative of impaired synaptic plasticity). It may be surmised that 12 weeks fed with HFD induce a systemic insulin resistance that impacts profoundly on brain activity, i.e., synaptic plasticity.

Publication types

  • Research Support, N.I.H., Extramural

MeSH terms

  • Animals
  • Blood Glucose / metabolism
  • Dietary Fats / adverse effects
  • Dietary Fats / pharmacology*
  • Glucose Transporter Type 3 / metabolism
  • Glucose Transporter Type 4 / metabolism
  • Hepatocytes / metabolism*
  • Hepatocytes / pathology
  • Insulin Receptor Substrate Proteins / metabolism
  • Insulin Resistance*
  • Liver / metabolism*
  • Liver / pathology
  • MAP Kinase Signaling System / drug effects*
  • Mice
  • NF-kappa B / metabolism
  • Neuronal Plasticity / drug effects*
  • Nitric Oxide Synthase Type II / metabolism
  • Triglycerides / blood

Substances

  • Blood Glucose
  • Dietary Fats
  • Glucose Transporter Type 3
  • Glucose Transporter Type 4
  • Insulin Receptor Substrate Proteins
  • Irs1 protein, mouse
  • NF-kappa B
  • Slc2a3 protein, mouse
  • Slc2a4 protein, mouse
  • Triglycerides
  • Nitric Oxide Synthase Type II
  • Nos2 protein, mouse